Evolent Health, Inc Class A Common Stock (EVH) is a publicly traded Healthcare sector company. As of May 21, 2026, EVH trades at $3.90 with a market cap of $438.68M and a P/E ratio of -0.80. EVH moved -0.64% today. Year to date, EVH is -2.28%; over the trailing twelve months it is -55.99%. Its 52-week range spans $2.10 to $29.59. Analyst consensus is strong buy with an average price target of $5.85. Rallies surfaces EVH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
EVH financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. EVH recently traded at $3.90. Market cap is $438.68M. P/E ratio is -0.80. Revenue is $1.89B.
| Metric | Value |
|---|---|
| Price | $3.90 |
| Market Cap | $438.68M |
| P/E Ratio | -0.80 |
| EPS | $-4.76 |
| Dividend Yield | 0.00% |
| 52-Week High | $29.59 |
| 52-Week Low | $2.10 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.89B |
| Net Income | $-533.78M |
| Gross Margin | 20.18% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.88B | $-579.40M | $-5.07 |
| 2024 | $2.55B | $-61.62M | $-0.81 |
| 2023 | $1.96B | $-113.04M | $-1.28 |
| 2022 | $1.35B | $-19.16M | $-0.20 |
14 analysts cover EVH: 0 strong buy, 12 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $5.85.